Biomea Fusion, Inc.

NASDAQ:BMEA

Biotechnology

Healthcare
$0.74 -2.50%

-$0.03 today

Market cap
$53.18M
Beta
-0.33
P/E (TTM)
-1.9
EPS (TTM)
-$0.62
52W Low $0.87High $2.99

Volume 3.50M

Average 1.52M

BMEA Other Current Assets

Current assets not reported separately, such as prepaid expenses.

Biomea Fusion, Inc.NASDAQ: BMEA

Other Current Assets · Q1 FY2026 · quarter ended Mar 2026

Other current assets rises 83.2% from a year ago

Other current assets stood at $1.63M at the end of Q1 FY2026, up 83.2% from a year earlier and down 27.4% from the prior quarter. Over 3 fiscal years it compounded at -22.3% a year.

Context

  • Other current assets amounted to 3.5% of total assets at the end of Q1 FY2026, up 1.9 pp from a year earlier.
  • Other current assets increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether other current assets keeps rising in the next quarterly balance sheet after a +83.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.63M-27.4% QoQ
Last fiscal yearDec 2025
$2.24M-77.7% YoY
Year agoMar 2025
$887K+83.2% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+83.2%——
1 year-77.7%——
3-year CAGR-22.3%——
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
2.24M USD
Year-over-year change
-77.7%

Other Current Assets vs competitors

How BMEA compares with its peers on the latest reported figures

  • BMEA's Mar 2026 other current assets of $1.63M is the 6th highest of the 9 companies compared; the peer median is $2.49M.
  • Its year-over-year change of +83.2% is the 2nd highest of 8, against a peer median of -30.1%.
  • Other current assets amounts to 3.5% of total assets for BMEA, versus a peer median of 2.4%.
BMEA Competitors Peer median
Other Current Assets for BMEA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
STROSutro Biopharma, Inc.Mar 2026$5.93M -76.2%-22.1%2.5%
ALXOALX Oncology Holdings Inc.Mar 2026$5.24M —+5.8%2.9%
CAMPCAMP4 Therapeutics CorporationMar 2026$2.99M +725.4%—2.8%
GUTSFractyl Health, Inc. Common StockMar 2026$2.75M -44.3%+36.8%2.8%
PMVPPMV Pharmaceuticals, Inc.Mar 2026$2.23M -28.3%-27.3%2.3%
BMEABiomea Fusion, Inc.Mar 2026$1.63M +83.2%-22.3%3.5%
UNCYUnicycive Therapeutics, Inc.Mar 2026$1.09M -20.4%+94.6%1.7%
IMUXImmunic, Inc.Mar 2026$1.06M -54.7%-30.6%0.6%
CBUSCibus, Inc.Mar 2026$941K -30.1%+27.0%0.3%
Peer median (excluding BMEA) $2.49M-30.1%+5.8%2.4%

Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents145.74M111.9M176.87M58.28M55.81M
Short-term Investments27.78M1.15M000
Net Receivables00000
Inventory00000
Other Current Assets04.77M2.32M10.05M2.24M
Total Current Assets176.56M117.82M179.18M68.33M58.05M
Property, Plant & Equipment (Net)5.69M7.99M14.87M10.62M153K
Goodwill00000
Intangible Assets00000
Long-term Investments1.88M000369K
Tax Assets00000
Other Non-current Assets1.58M3.5M5.87M988K0
Total Non-current Assets9.14M11.49M20.75M11.61M522K
Total Assets185.71M129.31M199.93M79.94M58.57M
Account Payables1.33M6.83M6.85M12.93M3.23M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities480K636K192K203K169K
Total Current Liabilities4.64M19.1M22.86M21.67M11.1M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities000017.79M
Total Non-current Liabilities2.29M1.67M7.83M6.69M17.92M
Total Liabilities6.92M20.77M30.69M28.37M29.02M
Common Stock3K3K4K4K7K
Retained Earnings(49.74M)(131.57M)(248.83M)(387.25M)(449.05M)
Accumulated OCI(10K)(1K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity178.78M108.54M169.24M51.57M29.55M
Total Debt2.85M2.29M10.3M8.77M1.59M
Net Debt(142.89M)(109.61M)(166.57M)(49.51M)(54.22M)

Biomea Fusion, Inc.

NASDAQ:BMEA

Intrinsic Alpha fair value

Locked

Current Price

$0.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.